❗️Postdoc position in Montreal❗️Please retweet! My former PhD advisor Simona Brambati is looking for a postdoc in computational neuroscience to investigate sex differences in the language network using multimodal imaging/AI. Email your CV to [email protected].

I am looking for a motivated PhD student to come work with me at the Douglas Research Centre McGill University on an exciting project combining neuroimaging and transcriptomics to study aging and brain disorders/neurodegeneration, starting from January 2024. Please RT!

Announcing our exciting speaker lineup for Atypical Alzheimer's Disease PIA day scientific session on July 15 at #AAIC23, Amsterdam! Join Marianne Chapleau Maxime Montembeault Neha A Singh Niels Reijner Celeste Laureyssen Felipe Luiz Pereira who will discuss clinical, imaging, genetics aspects and more in #AtypicalAD.

Our short review on recent (~2022) neuroimaging papers in atypical Alzheimer's disease variants with Lara Migliaccio is out in Current Opinion in Neurology ✨ journals.lww.com/co-neurology/A…

Fantastic and productive Include meeting in Amsterdam, with friends and colleagues from all over the world. For more equitable language research on brain health. Universidad de San Andrés Centro de Neurociencias Cognitivas Facultad de Humanidades USACH Global Brain Health Institute Atlantic Fellows Include Network LAC-CD ReDLat Dementia GERO

Some #AAIC23 highlights 💜

Extended Deadline September 20th, 5pm PST!

New paper alert! With my amazing (now ex-) student @AGeraudie and other colleagues from the UCSF MAC and ALBA Language Neurobiology laboratory

🤩

New editorial out in Brain: Brain MRI research in neurodegenerative dementia: time to deliver on promises academic.oup.com/brain/article/…

The #CASResearchGroup "Tools for Transnational Neuropsychiatric Research" led by Nikos Nikolaos Koutsouleris & Johannes Levin @LMU_Uniklinikum has successfully started at Schloss Fürstenried. We look forward to welcoming the fellows of the #CASResearchGroup for their longer stays.

A cheerful Hi 👋 from the #EMRC of the #ISFTD to all FTD researchers all over the world! Are you an early or mid career researcher in the #FTD field yourself and want to connect, come join the EMCR breakfast during the ISFTD conference in Amsterdam this year! See you there 🌷

CAS warmly welcomes Maxime Montembeault Maxime Montembeault Douglas Research Centre McGill University as #CASFellow and member of Nikolaos Nikolaos Koutsouleris and Johannes Levin's #CASResearchGroup "Tools for Transnational Neuropsychiatric Research“. @LMU_Uniklinikum @DZNE_de @SyNergy_Cluster

Can a simple blood test be used to identify normal individuals who will develop clinical AD? 🤔 💡Our study suggests so: Abnormal plasma p-tau217 levels predict cognitive impairment in healthy individuals when followed for up to 10 years after blood donation. Preprint link 👇

Our new lab paper suggests that almost all (between 75-90%) cognitively intact people with abnormal plasma p-tau217 values subsequently developed MCI when followed for <10 years after their blood test. (14% in A-T-) I have mixed feeling of being happy and scarred... 😳#Alzheimer

Well done Anna! And congratulations on your award for the best talk! 🤩

Thank you so much Alzheimer Society of Canada and Brain Canada for your support on our project "Novel digital and adaptive marker of word-finding difficulties for early detection of Alzheimer’s disease"! 🧠

Congratulations to Dr. Maxime Montembeault who received a Insight Development Grant from SSHRC! Read more : douglas.research.mcgill.ca/news/dr-maxime… *** Félicitations au Dr Maxime Montembeault qui a reçu une subvention de développement Savoir du CRSH! En savoir plus : douglas.research.mcgill.ca/fr/news/dr-max…

Join us in Toronto, Canada or online, July 27 - 31, for the Alzheimer's Association’s #AAIC25! I'll be speaking on biomarkers and preclinical AD on July 27th and 31th. I hope to see you there at the world’s largest international conference on dementia research.